(ALAB) Astera Labs - Overview
Sector: Technology | Industry: Semiconductors | Exchange: NASDAQ (USA) | Market Cap: 52.602m USD | Total Return: 254.9% in 12m
Avg Turnover: 1.56B
Qual. Beats: 4
Rev. Trend: 99.3%
Qual. Beats: 5
Warnings
P/E ratio 208.8
Beneish M-Score 1.00 > -1.5 - likely earnings manipulation
Tailwinds
Supp Ema20, Rs Leader, Idiosyncratic Leader, Tailwind, Confidence
Astera Labs, Inc. (ALAB) specializes in semiconductor-based connectivity solutions designed to optimize data transmission within cloud and artificial intelligence infrastructure. The company’s core offering is an intelligent connectivity platform that integrates high-speed mixed-signal hardware with the COSMOS software suite for fleet-level resource management. Its product portfolio includes PCIe/CXL retimers, Ethernet cable modules, and memory connectivity controllers tailored for hyperscale data centers and original equipment manufacturers.
The business operates within the high-growth data center interconnect market, where increasing AI workloads drive demand for low-latency, high-bandwidth communication between GPUs and memory. As a fabless semiconductor firm, Astera Labs focuses on design and intellectual property while outsourcing the capital-intensive manufacturing process to third-party foundries. For a deeper look into the companys valuation metrics and competitive positioning, consider exploring the data available on ValueRay.
- Hyperscaler demand for AI infrastructure drives adoption of Aries PCIe retimers
- Expansion of Taurus Ethernet Smart Cable Modules increases market share in data centers
- Deployment of Leo CXL memory controllers boosts revenue from high-performance computing
- High customer concentration among cloud giants creates significant revenue volatility risk
- Production scaling and manufacturing yields impact gross margins for connectivity solutions
| Net Income: 267.6m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.21 > 0.02 and ΔFCF/TA 11.02 > 1.0 |
| NWC/Revenue: 128.6% < 20% (prev 203.6%; Δ -74.98% < -1%) |
| CFO/TA 0.23 > 3% & CFO 383.4m > Net Income 267.6m |
| Net Debt (-1.15b) to EBITDA (256.8m): -4.46 < 3 |
| Current Ratio: 11.30 > 1.5 & < 3 |
| Outstanding Shares: last quarter (181.2m) vs 12m ago 1.71% < -2% |
| Gross Margin: 75.99% > 18% (prev 0.76%; Δ 7.52k% > 0.5%) |
| Asset Turnover: 72.02% > 50% (prev 43.73%; Δ 28.30% > 0%) |
| Interest Coverage Ratio: error (cannot be calculated; needs correct EBITDA TTM and Interest Expense TTM) |
| A: 0.78 (Total Current Assets 1.41b - Total Current Liabilities 125.0m) / Total Assets 1.66b |
| B: 0.05 (Retained Earnings 90.6m / Total Assets 1.66b) |
| C: 0.18 (EBIT TTM 247.4m / Avg Total Assets 1.39b) |
| D: 0.54 (Book Value of Equity 89.9m / Total Liabilities 165.3m) |
| Altman-Z'' = 7.04 = AAA |
| DSRI: 0.95 (Receivables 134.8m/69.8m, Revenue 1.00b/490.5m) |
| GMI: 1.00 (GM 75.99% / 75.76%) |
| AQI: 15.75 (AQ_t 0.09 / AQ_t-1 0.01) |
| SGI: 2.04 (Revenue 1.00b / 490.5m) |
| TATA: -0.07 (NI 267.6m - CFO 383.4m) / TA 1.66b) |
| Beneish M = 6.35 (Cap -4..+1) = D |
As of May 31, 2026, the stock is trading at USD 342.85 with a total of 5,885,373 shares traded.
Over the past week, the price has changed by +15.11%,
over one month by +74.17%,
over three months by +188.52% and
over the past year by +254.88%.
Astera Labs has received a consensus analysts rating of 4.47. Therefore, it is recommended to buy ALAB.
- StrongBuy: 9
- Buy: 7
- Hold: 1
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 244.1 | -28.8% |
P/E Trailing = 208.7619
P/E Forward = 101.0101
P/S = 50.9785
P/B = 34.1726
Revenue TTM = 1.00b USD
EBIT TTM = 247.4m USD
EBITDA TTM = 256.8m USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = 39.3m USD (from shortLongTermDebtTotal, last fiscal year) + Leases 4.15m
Net Debt = -1.15b USD (calculated: Debt 39.3m - CCE 1.18b)
Enterprise Value = 51.5b USD (52.6b + Debt 39.3m - CCE 1.18b)
Interest Coverage Ratio = unknown (Ebit TTM 247.4m / Interest Expense TTM 0.0)
EV/FCF = 150.1x (Enterprise Value 51.5b / FCF TTM 342.8m)
FCF Yield = 0.67% (FCF TTM 342.8m / Enterprise Value 51.5b)
FCF Margin = 34.23% (FCF TTM 342.8m / Revenue TTM 1.00b)
Net Margin = 26.72% (Net Income TTM 267.6m / Revenue TTM 1.00b)
Gross Margin = 75.99% ((Revenue TTM 1.00b - Cost of Revenue TTM 240.5m) / Revenue TTM)
Gross Margin QoQ = 76.26% (prev 75.57%)
Tobins Q-Ratio = 31.01 (Enterprise Value 51.5b / Total Assets 1.66b)
Interest Expense / Debt = 0.0% (Interest Expense 0.0 / Debt 39.3m)
Taxrate = 21.0% (US default 21%)
NOPAT = 195.4m (EBIT 247.4m * (1 - 21.00%))
Current Ratio = 11.30 (Total Current Assets 1.41b / Total Current Liabilities 125.0m)
Debt / Equity = 0.03 (Debt 39.3m / totalStockholderEquity, last quarter 1.49b)
Debt / EBITDA = -4.46 (Net Debt -1.15b / EBITDA 256.8m)
Debt / FCF = -3.34 (Net Debt -1.15b / FCF TTM 342.8m)
Total Stockholder Equity = 1.32b (last 4 quarters mean from totalStockholderEquity)
RoA = 19.25% (Net Income 267.6m / Total Assets 1.66b)
RoE = 20.33% (Net Income TTM 267.6m / Total Stockholder Equity 1.32b)
RoCE = 16.12% (EBIT 247.4m / Capital Employed (Total Assets 1.66b - Current Liab 125.0m))
RoIC = 12.92% (NOPAT 195.4m / Invested Capital 1.51b)
WACC = 17.59% (E(52.6b)/V(52.6b) * Re(17.60%) + D(39.3m)/V(52.6b) * Rd(0.0%) * (1-Tc(0.21)))
Discount Rate = 17.60% (= CAPM, Blume Beta Adj.) -> capped to 13.17%
Shares (quarterly) Correlation: 84.11 | Cagr: 102.5%
[DCF] Terminal Value 53.72% ; FCFF base≈249.0m ; Y1≈285.4m ; Y5≈420.0m
[DCF] Fair Price = 20.47 (EV 2.36b - Net Debt -1.15b = Equity 3.51b / Shares 171.4m; r=17.59% [WACC]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: N/A | EPS CAGR: N/A | SUE: 1.27 | # QB: 4
Revenue Correlation: 99.25 | Revenue CAGR: 172.1% | SUE: 2.18 | # QB: 5
EPS current Quarter (2026-06-30): EPS=0.69 | Chg30d=+25.82% | Revisions=+83% | Analysts=22
EPS next Quarter (2026-09-30): EPS=0.79 | Chg30d=+22.65% | Revisions=+83% | Analysts=21
EPS current Year (2026-12-31): EPS=3.00 | Chg30d=+20.74% | Revisions=+84% | GrowthEPS=+63.2% | GrowthRev=+81.3%
EPS next Year (2027-12-31): EPS=4.21 | Chg30d=+17.60% | Revisions=+83% | GrowthEPS=+40.1% | GrowthRev=+42.0%
[Analyst] Revisions Ratio: +84%